CoChat

Increased prevalence of heterozygous 21‐OH germline mutations in patients with adrenal incidentalomas

Baumgartner‐Parzer, S. M., Pauschenwein, S., Waldhäusl, W., Pölzler, K., Nowotny, P., Vierhapper, H. · 2002 · Clinical Endocrinology
Cited by 32

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Summary: objective As a result of the widespread use and the enhanced quality of high‐resolution radiological techniques [computed tomography (CT), magnetic resonance imaging (MRI)] a high frequency (4–10%) of adrenal incidentalomas has been detected in the general population. It is still debated whether undiagnosed 21‐hydroxylase (21‐OH) deficiency, accounting for more than 90% of congenital adrenal hyperplasia (CAH) cases, predisposes for adrenal tumours. We therefore performed an analysis of the prevalence of 21‐OH germline mutations in patients with non‐functional adrenal incidentalomas. subjects and methods Fifty Austrian patients with non‐functional adrenal adenomas detected by CT for unrelated reasons were screened by PCR‐based sequencing for the most common point mutations and by Southern blot analysis for large gene deletion/conversion events of the 21‐OH gene. results Heterozygosity for large gene conversions was shown in 5 (10%), for Q318 point mutations in 2 (4%) and for the Intron2splice mutation in 1 (2%) of the 50 patients with adrenal adenomas. One (2%) patient (70 years of age), identified to have a chimeric CYP21AB gene with a junction site before Intron 2 on one and a large (30 kb) deletion on the other allele, was diagnosed to be affected by CAH. conclusion 21‐OH mutation screening indicates a higher frequency of classic CAH carriers (16%) and of manifest CAH (2%) due to 21‐OH‐deficiency among patients with adrenal adenomas than in the general population (1–2% carrier frequency for classic CAH).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2002.01299.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Metadata

Authors
Baumgartner‐Parzer, S. M., Pauschenwein, S., Waldhäusl, W., Pölzler, K., Nowotny, P., & Vierhapper, H.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2002-06
Volume
56
Issue
6
Pages
811-816
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1999072432
Cited by
32
References
8
FWCI
0.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased prevalence of heterozygous 21‐OH germline mutations in patients with adrenal incidentalomas. https://app.cochat.ai/papers/10.1046/j.1365-2265.2002.01299.x
The paper
Baumgartner‐Parzer, S. M., Pauschenwein, S., Waldhäusl, W., Pölzler, K., Nowotny, P., & Vierhapper, H. (2002). Increased prevalence of heterozygous 21‐OH germline mutations in patients with adrenal incidentalomas. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2002.01299.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.